Loteprednol Etabonate Suspension Eye Drops (Lotemax) is a corticosteroid medication for ophthalmic use, mainly indicated for the treatment of inflammatory eye diseases. As a topically administered glucocorticoid preparation, it holds an important position in clinical ophthalmic practice.

Indications for Loteprednol Etabonate Suspension Eye Drops (Lotemax)

Postoperative Inflammation Control

Used for the treatment and prevention of ocular inflammation after cataract surgery.

As part of the postoperative anti-inflammatory regimen, it can effectively reduce the inflammatory response caused by surgery.

Allergic Conjunctivitis

Indicated for relieving symptoms of ocular pruritus, hyperemia, and inflammation caused by allergic conjunctivitis.

Its anti-inflammatory effect can significantly improve ocular discomfort resulting from allergic reactions.

Other Ocular Inflammations

Can be used to treat ocular inflammation caused by various factors, including non-infectious conjunctivitis, iritis, etc.

Specifications and Properties of Loteprednol Etabonate Suspension Eye Drops (Lotemax)

Dosage Form and Specifications

The common specification is a sterile suspension with a concentration of 0.5%, usually packaged in plastic eye drop bottles with a volume of 2.5ml, 5ml, or 10ml.

Main Ingredients

Each milliliter contains 5mg of loteprednol etabonate (0.5% concentration).

Excipients include glycerin, polysorbate 80, hydroxyethyl cellulose, disodium edetate, benzalkonium chloride, etc. The specific formula may vary slightly among different manufacturers.

Physical Properties

It is a white to off-white suspension liquid. Stratification may occur when left standing, so it must be shaken well before use.

The pH value is adjusted to be close to the pH range of tear fluid to reduce irritation during instillation.

Storage Methods for Loteprednol Etabonate Suspension Eye Drops (Lotemax)

Temperature Requirements

It is recommended to store at room temperature (15-25°C), avoiding freezing and high temperatures.

Extreme temperatures may affect the stability and sterility of the medication.

Light-Proof Storage

Should be kept in the original packaging to avoid direct sunlight.

Light may accelerate the degradation of certain components.

Usage Period After Opening

Generally, it can be used for 4 weeks after opening. Even if the medication is not used up after this period, it should be discarded.

For the specific storage period, refer to the product instruction manual.

Other Precautions

Keep the bottle mouth clean to avoid contamination. Tightly close the bottle cap after each use.

The medication should be placed out of the reach of children.

Any medication with changes in color, precipitation, or other physical properties should not be used continuously.